Showing results (51-60 of 150) with videos related to
Sort By:
Pageof 15
The European Respiratory Journal|July 4, 2024
Phenotypes in pulmonary hypertensionJason Weatherald, Anna R Hemnes, Bradley A Maron, et al.International Journal of Cardiology. Congenital Heart Disease|December 23, 2024
Corrigendum to "Exercise ventilatory reserve predicts survival in adult congenital heart disease associated pulmonary arterial hypertension with Eisenmenger physiology" [Int J Cardiol Congenit Heart Dis, Volume 7, March 2022, 100331]Chinthaka B Samaranayake, Ruth McNiven, Aleksander Kempny, et al.International Journal of Cardiology. Congenital Heart Disease|December 23, 2024
Exercise ventilatory reserve predicts survival in adult congenital heart disease associated pulmonary arterial hypertension with Eisenmenger physiologyChinthaka B Samaranayake, Ruth McNiven, Aleksander Kempny, et al.International Journal of Cardiology|August 3, 2019
A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot studyHeba Nashat, Aleksander Kempny, Carl Harries, et al.Pulmonary Circulation|April 5, 2019
Early histological changes of pulmonary arterial hypertension disclosed by invasive cardiopulmonary exercise testingYousaf J Bhatti, Alexandra J Rice, Aleksander Kempny, et al.The Lancet. Respiratory Medicine|August 17, 2023
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and managementKaren M Olsson, Tamera J Corte, Jan C Kamp, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|July 16, 2016
Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertensionAthanasios Charalampopoulos, J Simon R Gibbs, Rachel J Davies, et al.Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Treatment goals of pulmonary hypertension]Vallerie V McLaughlin, Sean Patrick Gaine, Luke S Howard, et al.Pulmonary Circulation|January 23, 2015
Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factorsAthanasios Charalampopoulos, Luke S Howard, Ioanna Tzoulaki, et al.Journal of the American College of Cardiology|December 21, 2013
Treatment goals of pulmonary hypertensionVallerie V McLaughlin, Sean Patrick Gaine, Luke S Howard, et al.Pageof 15